Cargando…

FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.

The Forkhead box P3 (FOXP3) transcription factor is the key driver of regulatory T cell (Treg cells) differentiation and immunosuppressive function. In addition, FOXP3 has been reported to be expressed in many tumors, including melanoma. However, its role in tumorigenesis is conficting, with both tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, BeeShin, Anaka, Matthew, Deb, Siddhartha, Freyer, Claudia, Ebert, Lisa M., Chueh, Anderly C., Al-Obaidi, Sheren, Behren, Andreas, Jayachandran, Aparna, Cebon, Jonathan, Chen, Weisan, Mariadason, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2013
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960207/ https://www.ncbi.nlm.nih.gov/pubmed/24406338

Ejemplares similares

Identifying and targeting determinants of melanoma cellular invasion
por: Jayachandran, Aparna, et al.
Publicado: (2016)

Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells
por: Jayachandran, Aparna, et al.
Publicado: (2016)

Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion
por: Prithviraj, Prashanth, et al.
Publicado: (2015)

Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma
por: Jayachandran, Aparna, et al.
Publicado: (2014)

DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis
por: Tögel, Lars, et al.
Publicado: (2018)

Author Correction: DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis
por: Tögel, Lars, et al.
Publicado: (2023)

Systems analysis identifies miR-29b regulation of invasiveness in melanoma
por: Andrews, Miles C., et al.
Publicado: (2016)

Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma
por: Woods, Katherine, et al.
Publicado: (2016)

Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors
por: Anaka, Matthew, et al.
Publicado: (2013)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

Effects of Epithelial to Mesenchymal Transition on T Cell Targeting of Melanoma Cells
por: Woods, Katherine, et al.
Publicado: (2014)

Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer
por: Chüeh, Anderly C., et al.
Publicado: (2017)

Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes
por: Prithviraj, Prashanth, et al.
Publicado: (2020)

Embryonic Chicken Transplantation is a Promising Model for Studying the Invasive Behavior of Melanoma Cells
por: Jayachandran, Aparna, et al.
Publicado: (2015)

A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma
por: Ebert, Lisa M., et al.
Publicado: (2012)

Alternate antigen processing in the presence of gamma interferon may misdirect the immune recognition of cancer
por: Woods, Katherine, et al.
Publicado: (2015)

PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation
por: Tutuka, Candani S. A., et al.
Publicado: (2017)

VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer
por: Chionh, Fiona, et al.
Publicado: (2022)

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations
por: Chang-Hao Tsao, Simon, et al.
Publicado: (2015)

Tracking extracellular vesicle phenotypic changes enables treatment monitoring in melanoma
por: Wang, Jing, et al.
Publicado: (2020)

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
por: Lee, Erinna F., et al.
Publicado: (2019)

Capture and On-chip analysis of Melanoma Cells Using Tunable Surface Shear forces
por: Tsao, Simon Chang-Hao, et al.
Publicado: (2016)

Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma
por: Shrestha, Ritu, et al.
Publicado: (2018)

Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette–Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma
por: Da Gama Duarte, Jessica, et al.
Publicado: (2018)

Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study
por: Cao, Lu, et al.
Publicado: (2021)

Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma
por: Wong, Stephen Q., et al.
Publicado: (2014)

A Central Role for Foxp3+ Regulatory T Cells in K-Ras-Driven Lung Tumorigenesis
por: Granville, Courtney A., et al.
Publicado: (2009)

Characterising the phenotypic evolution of circulating tumour cells during treatment
por: Tsao, Simon Chang-Hao, et al.
Publicado: (2018)

Intercellular Resistance to BRAF Inhibition Can Be Mediated by Extracellular Vesicle–Associated PDGFRβ()
por: Vella, Laura J., et al.
Publicado: (2017)

Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses
por: Da Gama Duarte, Jessica, et al.
Publicado: (2021)

Epigenetic Control of the foxp3 Locus in Regulatory T Cells
por: Floess, Stefan, et al.
Publicado: (2007)

PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma
por: Parakh, Sagun, et al.
Publicado: (2021)

The Ratio of GrzB(+) − FoxP3(+) over CD3(+) T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic Melanoma
por: Scognamiglio, Giosuè, et al.
Publicado: (2021)

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma
por: Halse, H., et al.
Publicado: (2018)

FOXP3 in Melanoma with Regression: Between Tumoral Expression and Regulatory T Cell Upregulation
por: Cioplea, Mirela, et al.
Publicado: (2020)

Conserved regulation of neurodevelopmental processes and behavior by FoxP in Drosophila
por: Castells-Nobau, Anna, et al.
Publicado: (2019)

Selective depletion of Foxp3(+) regulatory T cells induces a scurfy-like disease
por: Lahl, Katharina, et al.
Publicado: (2007)

Identification of CD24 as a marker for tumorigenesis of melanoma
por: Tang, Ming-Rui, et al.
Publicado: (2018)

LINE Retrotransposon RNA Is an Essential Structural and Functional Epigenetic Component of a Core Neocentromeric Chromatin
por: Chueh, Anderly C., et al.
Publicado: (2009)

Correction: LINE Retrotransposon RNA Is an Essential Structural and Functional Epigenetic Component of a Core Neocentromeric Chromatin
por: Chueh, Anderly C., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_c9emb5v8k67jopphvut4jot9m7